Drug-Virus Interaction: Effect of Administration of Recombinant Adenoviruses on the Pharmacokinetics of Docetaxel in a Rat Model

Modern cancer therapy combines recombinant viruses with traditional chemotherapeutic agents that are metabolized by hepatic cytochrome P450 3A4 (CYP3A4). A single dose of recombinant adenovirus (Ad) expressing beta-galactosidase (AdlacZ) significantly alters CYP3A2, the correlate of CYP3A4, in rats...

Descripción completa

Detalles Bibliográficos
Autores principales: Wonganan, Piyanuch, Zamboni, William C., Strychor, Sandra A., Dekker, Joseph D., Croyle, Maria A.
Formato: Texto
Lenguaje:English
Publicado: 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765861/
https://www.ncbi.nlm.nih.gov/pubmed/19110543
http://dx.doi.org/10.1038/cgt.2008.99

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765861/
https://www.ncbi.nlm.nih.gov/pubmed/19110543
http://dx.doi.org/10.1038/cgt.2008.99

Ejemplares similares